Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Salbutamol for Scar Improvement
NCT03514615Phase 1Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in scarring comparing Active Gel with Placebo Gel (2 arms). Primary endpoint: Peak plasma concentration at 24 hours. Started Jan 2018; status: completed.
02
Drugs
salbutamol
03
Conditions
scarring
Beyond the preview
Go deeper on NCT03514615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03514615.